GK
Guttahalli Krishnappa Shridhar
About Guttahalli Krishnappa Shridhar
Data last updated:
Guttahalli Krishnappa Shridhar is a Director at Dhanvanthri Speciality Pharma Private Limited (since 2015) and Whole-Time Director at Dhanvanthri Super Speciality Private Limited (since 2023). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹299 Cr; the largest is Dhanvanthri Speciality Pharma Private Limited at ₹173 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Mar 2015 | 2015 | ₹173 Cr (FY 2024) | Active | |
| Whole-Time Director | 11 Aug 2023 | 2023 | ₹126 Cr (FY 2025) | Active |
Board colleagues of Guttahalli Krishnappa Shridhar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhavya Balaraj | 06973461 | Dhanvanthri Speciality Pharma Private Limited , Dhanvanthri Super Speciality Private Limited | Director |
| Kushal Ashok Shah | 07743004 | Dhanvanthri Super Speciality Private Limited | Additional Director |
| Manish Kumar | 11135203 | Dhanvanthri Super Speciality Private Limited | Additional Director |
| Nikesh Kesarimal Oswal | 07895357 | Dhanvanthri Super Speciality Private Limited | Additional Director |
| Sambit Mohanty | 09302845 | Dhanvanthri Super Speciality Private Limited | Director |
| Satyendra Tiwari | 10686770 | Dhanvanthri Super Speciality Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Guttahalli Krishnappa Shridhar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Guttahalli Krishnappa Shridhar
Guttahalli Krishnappa Shridhar currently holds 2 directorships: Dhanvanthri Speciality Pharma Private Limited (Director, since 31 Mar 2015, revenue ₹173 Cr (FY 2024)); Dhanvanthri Super Speciality Private Limited (Whole-Time Director, since 11 Aug 2023, revenue ₹126 Cr (FY 2025)).
Guttahalli Krishnappa Shridhar was first appointed on 31 Mar 2015 as Director at Dhanvanthri Speciality Pharma Private Limited. The most recent appointment on record is 11 Aug 2023 at Dhanvanthri Super Speciality Private Limited.
The 2 current companies of Guttahalli Krishnappa Shridhar that report revenue have a combined latest revenue of ₹299 Cr: Dhanvanthri Speciality Pharma Private Limited ₹173 Cr (FY 2024); Dhanvanthri Super Speciality Private Limited ₹126 Cr (FY 2025).
The current boards of Guttahalli Krishnappa Shridhar's companies include Bhavya Balaraj (Dhanvanthri Speciality Pharma Private Limited), Kushal Ashok Shah (Dhanvanthri Super Speciality Private Limited), Manish Kumar (Dhanvanthri Super Speciality Private Limited), Nikesh Kesarimal Oswal (Dhanvanthri Super Speciality Private Limited), Sambit Mohanty (Dhanvanthri Super Speciality Private Limited), Satyendra Tiwari (Dhanvanthri Super Speciality Private Limited).